Another year comes to an end, and we want to thank each, and every one of you for working with us and trusting our teams. Together we have reached many milestones taking your product further up the value chain. We’ve had a very busy year with many new projects and partnerships created. It is greatly rewarding to work with you on important studies as this keeps us highly motivated knowing that ultimately these products will become treatment options improving the lives of patients.
It is with great honor and satisfaction that we celebrate the new partnerships we’ve built this year to strengthen our offering as your Strategic CRO partner thereby coming closer to your product development from early development all the way to market access.
This year alone, we’ve established an even greater, broader, and stronger Regulatory team which now covers all aspects of product development from CMC, translations, variations, scientific advice, and strategy all the way to the market authorisation and maintenance. We have strengthened our Real-World Evidence and Market Access team both internally and externally with additions to the team and our partnership with Medaffcon. This new partnership gives us local RWE/MA expertise in Finland in addition to the rest of the Nordics. In June, we established our partnership with Insife offering a stronger and improved technological state-of-the-art solution for Safety and Pharmacovigilance. However, above all, LINK Medical will deliver high-quality clinical trials covering both Europe and the US.
Together we’ve grown as a company overcoming many challenges utilizing our strong leadership, company culture, and a common desire to be the best CRO in Northern Europe.
Now as we wine down to end the year, we want to wish you a very nice holiday break and all the best wishes for next year.
Ola Gudmundsen, CEO